Open in interactive viewer → charts, metric popovers & call review

ICL's Sulfur Peak: A 1% Quarter Sold as a 2027 Story

Record raw-material costs flattened EBITDA growth to a crawl — but management says the worst sulfur is already bought, and everything now lands next year
ICL.TA · Earnings Call · 2026-11-11

The quarter that was about everything except growth

Sales of $1.9 billion rose 3%. Adjusted EBITDA of $402 million rose 1%. Gross margin climbed 30 basis points to 32.9%, the best since the fourth quarter of 2024. Adjusted net income of $126 million, or $0.10 per share. Free cash flow $66 million on operating cash flow of $256 million, with inventory swelling on softer commodity phosphate demand and higher sulfur inventory values. Guidance of $1.5–1.7 billion was reiterated with a stated target to land ahead of the midpoint; potash volumes stay 4.5–4.7 million tonnes; the adjusted tax rate stays near 30%. That is a company treading water while a raw material tries to drown it. Elad Aharonson's framing was explicit: “This growth was achieved despite record high raw material prices and elevated freight and logistics costs.” — Elad Aharonson, Executive or Senior Management (likely CEO or similar, based on leading the call and remarks) · 2026-11-11 The word he chose for the quarter was "resilience" — "This quarter was all about leading with resilience." Reasonable, but note what it implies: when the diversified machine produces 1% EBITDA growth, resilience becomes the headline instead of growth. The diverse portfolio is doing its job as an offset, not as an accelerant.

Sulfur: the peak that hasn't reached the P&L yet

The dominant fact of the quarter is that the average spot price of sulfur rose more than 220% year-over-year. High sulfur prices sits at the very top of this company's keyword table, above everything else management said. It hit Phosphate Solutions and Growing Solutions margins simultaneously — and Phosphate still printed a 20% EBITDA margin on $589 million of sales, producing $118 million of EBITDA, precisely because the portfolio carries specialty alongside commodity. Then the crucial nuance, which is the single most important sentence in the release cycle:

The peak of the sulfur purchase prices we saw back in August. Since August, the sulfur prices that we buy are getting lower and lower. However, it takes time to consume the sulfur from the inventory all the way to the finished goods and then out of the inventory. So in that respect, Q4 will reflect higher cost of sulfur in the P&L versus Q3.

Elad Aharonson, Executive or Senior Management (likely CEO or similar, based on leading the call and remarks) · 2026-11-11
Sit with that. The purchase-pressure peak is behind; the reported cost peak is still ahead, in Q4. October spot sulfur fell roughly 12% versus the third-quarter average, and purchase price relief is flagged to reach results in the first quarter of 2027. So the sequence investors are being asked to underwrite is: worse optics in Q4, better economics in Q1. This is not a new theme — it is a four-quarter grind that has finally inverted. In February, sulfur had gone from $140–150 a tonne to more than $500 and Elad called it “a headache for us” — Elad Aharonson · 2026-02-18. By August, it was “one of the main issues for the remainder of the year” — Elad Aharonson, CEO · 2026-08-05 with consumption costs still rising. Rate of change matters more than level here, and the rate of change has turned.

Brazil: a promise quietly retired

Growing Solutions did $538 million of sales and $44 million of EBITDA — a low-single-digit margin business being squeezed from both ends. Growing Solutions is the company's highest-ranked keyword this quarter, and not because it is thriving. The honest read requires looking backward. In February, on the fourth-quarter call, Elad said of Brazil: “I do believe that next year -- or this year, 2026, will be better for us.” — Elad Aharonson · 2026-02-18 By August it had become: “Q3 will not be as strong as it should be. When we'll see the change, I don't know.” — Elad Aharonson, CEO · 2026-08-05 On this call, the forward promise was simply gone. What replaced it was structural defense — agribusiness at 25% of Brazil's GDP in 2025, more than half of internationally traded soybeans originating there — plus an admission that customers "delayed purchasing decisions and shifted to less premium products when possible." That is a management team that has stopped calling the turn in the Brazilian market. Given persistent farmer affordability and a soft second half in what should have been the high season, refusing to forecast a recovery is probably the right call, and a meaningful change in tone.

Where the narrative actually pivots

Strip out the commodity noise and two things changed structurally. First, a new organizational structure takes effect January 1, 2027: Nutrition Solutions absorbs the food, health and nutrition assets; Industrial Phosphate folds into Industrial Solutions; Growing Solutions stays dedicated to specialty crop nutrition; and Commodity Phosphates joins Potash as Essential Minerals. Second, ELEVATE finally has numbers attached — more than $350 million of annual EBITDA improvement by the end of 2028, more than $150 million by the end of 2027, split roughly 50–60% productivity, 30–40% external spend, 10–20% SG&A. Asaf Alperovitz was precise on timing: “We will start realizing the savings in Q4 -- in Q1, sorry, of next year, and we'll see a gradual increase naturally.” — Asaf Alperovitz, Executive or Senior Management (likely CFO or similar, based on financial discussion) · 2026-11-11 Analysts have pressed on this confidence for two straight quarters; the answer has not changed. What has changed is the vocabulary. The 2025 "new strategy" language — the specialty crop nutrition and food-solutions pillars — has thinned out. Strategic priorities and growth engine both lost momentum this quarter in the company's own keyword tracking, while the cost transformation program holds its ground. ICL has traded a growth narrative for a cost narrative. When your growth engine grows EBITDA 1%, that is the correct trade — but it is a different company than the one pitched a year ago. The genuine bright spot is Industrial Products: sales $347 million, up 18%; EBITDA $100 million, up nearly 50%; Bromine prices up nearly 40% year-over-year and rebounding in October to first-quarter levels on the back of electronics demand for flame retardants. Potash, by contrast, saw EBITDA fall about 7% as a mix shift toward India and China contracts dragged the realized price down 2% sequentially to $370 CIF, despite a 5% year-over-year gain. Elad's view on the nutrient: “Potash, we feel the market is stabilized. The demand is there. I don't see any drama towards 2027.” — Elad Aharonson, Executive or Senior Management (likely CEO or similar, based on leading the call and remarks) · 2026-11-11 Phosphate fertilizers, he argued, should see demand rise simply because "farmers will not be able to skip another season." One dissonant note worth flagging: the prepared remarks promise to "capture growth opportunities driven by AI infrastructure, robotics, cutting-edge semiconductors." ICL's actual exposure is bromine chemistry sold into electronics — real, but a derivative. And the theme being invoked is the very one the market tape is de-rating, with AI data center exposure among the sharpest 30-day decliners across the global universe. Chemicals dressed in AI clothes is a hard sell into that tape.

The whole case in one breath

The balance sheet allows the patience: net debt to adjusted EBITDA of 1.5x, $2.2 billion of available cash resources, and a policy of distributing 50% of adjusted net income — $63 million in the quarter, a 4.1% trailing yield. Elad closed with the investment case laid bare: “Q3 was a resilient quarter for us, taking everything into account. I think we performed very well. And I believe 2027 could be even better.” — Elad Aharonson, Executive or Senior Management (likely CEO or similar, based on leading the call and remarks) · 2026-11-11 That is the entire thesis. Sulfur relief, ELEVATE savings, phosphate demand recovery after a skipped season, a new segment structure — all of it lands in 2027. Investors are being asked to pay today for a recovery that has not yet shown up in a P&L, on the strength of a spot price move in October. It is the first hard evidence in four quarters that the headwind is turning. Whether it is also the last is the question the fourth quarter will answer — and Q4 is, by management's own admission, going to look worse before it looks better.